methylprednisolone
Drugsingle preoperative dose of methylprednisolone
NCT Number: NCT07507643
The purpose of this study is to test whether receiving methylprednisolone before surgery will reduce the side effects of having surgery, such as infections and longer hospital stays.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 3
Rush University Medical Center (Data collection only), Chicago, Illinois, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
≤40 mL/min as calculated by the Cockcroft-Gault Equation, currently on hemodialysis, currently on peritoneal dialysis.
single preoperative dose of methylprednisolone
Time frame: 30 days
To determine whether the administration of preoperative methylprednisolone will result in lower 30-day all-cause morbidity, compared with the standard of care (no methylprednisolone), in participants undergoing elective major hepatectomy for all indications.
Contact information is provided by the study sponsor or research team.
Michael D'Angelica, MD
CONTACT
Peter Kingham, MD
CONTACT
Memorial Sloan Kettering Cancer Center
Other
A Randomized Controlled Trial of Methylprednisolone Versus Standard of Care in Patients Undergoing Major Hepatectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03715517
Agnosia, Digestive System Diseases
Winnipeg, Manitoba, Canada
View Trial DetailsNCT07385521
Colorectal Liver Metastasis (CRLM), Hepatectomy
Milan, Italy
View Trial DetailsNCT07062380
Hepatecellular Carcinoma, Hepatectomy
Wuhan, Hubei, China
View Trial DetailsNCT06950827
Adenocarcinoma, Carcinoma
Chengdu, Sichuan, China
View Trial Details